No Dose Adjustment for Isavuconazole Based on Age or Sex

This phase 1, open-label, single-dose, parallel-group study evaluated the pharmacokinetics (PK) of isavuconazole after a single oral dose of the prodrug isavuconazonium sulfate in healthy nonelderly (age, 18 to 45 years) and elderly (age, ≥65 years) males and females. Overall, 48 subjects were enrol...

Descripción completa

Detalles Bibliográficos
Autores principales: Desai, Amit V., Han, David, Kowalski, Donna L., Lademacher, Christopher, Pearlman, Helene, Yamazaki, Takao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535513/
https://www.ncbi.nlm.nih.gov/pubmed/30962330
http://dx.doi.org/10.1128/AAC.02629-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535513/
https://www.ncbi.nlm.nih.gov/pubmed/30962330
http://dx.doi.org/10.1128/AAC.02629-18

Ejemplares similares